MedTrace Logo

Magnetic Resonance Imaging in the Evaluation of Liver Fibrosis

NCT01572064 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2012-09-18

No results posted yet for this study

Summary

The main purpose of this pilot study is to evaluate non-invasive magnetic resonance imaging (MRI) techniques in the detection and grading of liver fibrosis, so that the investigators can reduce the need of invasive techniques such as liver biopsy and transjugular hepatic venous portal pressure gradient (HVPG) measurements to assess the degree of liver scarring and portal hypertension.

Conditions

  • Liver Fibrosis

Interventions

PROCEDURE

Blood sample

1 fasted blood sample taken for metabolomics

OTHER

MRI Scan

1 single visit for MRI and MRS

Sponsors & Collaborators

  • University of Nottingham

    lead OTHER

Principal Investigators

  • Guruprasad P Aithal, PhD · University of Nottingham

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01572064 on ClinicalTrials.gov